Integer Holdings Corporation (NYSE:ITGR) Receives $97.25 Consensus PT from Analysts

Shares of Integer Holdings Corporation (NYSE:ITGR) have received an average recommendation of “Hold” from the eleven ratings firms that are presently covering the firm, Marketbeat Ratings reports. Seven analysts have rated the stock with a hold recommendation and four have given a buy recommendation to the company. The average 1-year target price among analysts that have updated their coverage on the stock in the last year is $97.25.

A number of research firms have issued reports on ITGR. Raymond James Financial restated an “outperform” rating and set a $95.00 price target (down from $143.00) on shares of Integer in a research note on Friday, October 24th. Wells Fargo & Company reissued an “equal weight” rating and issued a $80.00 price objective (down previously from $132.00) on shares of Integer in a report on Friday, October 24th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Integer in a report on Friday, October 31st. Piper Sandler decreased their price target on shares of Integer from $155.00 to $82.00 and set an “overweight” rating on the stock in a research report on Friday, October 24th. Finally, Truist Financial dropped their price target on shares of Integer from $88.00 to $86.00 and set a “buy” rating on the stock in a research note on Monday, November 24th.

Insider Buying and Selling

In related news, VP Tommy P. Thomas sold 884 shares of the stock in a transaction that occurred on Tuesday, November 11th. The shares were sold at an average price of $70.15, for a total value of $62,012.60. Following the completion of the sale, the vice president directly owned 3,596 shares of the company’s stock, valued at approximately $252,259.40. This represents a 19.73% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Cheryl C. Capps bought 1,600 shares of the firm’s stock in a transaction on Thursday, November 6th. The shares were purchased at an average price of $66.70 per share, for a total transaction of $106,720.00. Following the purchase, the director owned 11,702 shares in the company, valued at $780,523.40. This trade represents a 15.84% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Over the last ninety days, insiders acquired 5,843 shares of company stock worth $384,771. Company insiders own 2.16% of the company’s stock.

Hedge Funds Weigh In On Integer

A number of hedge funds have recently modified their holdings of ITGR. Tudor Investment Corp ET AL lifted its stake in Integer by 50,787.5% in the 3rd quarter. Tudor Investment Corp ET AL now owns 29,500,000 shares of the medical equipment provider’s stock worth $28,606,000 after purchasing an additional 29,442,029 shares in the last quarter. Alliancebernstein L.P. grew its position in shares of Integer by 885.1% during the second quarter. Alliancebernstein L.P. now owns 1,106,091 shares of the medical equipment provider’s stock valued at $136,016,000 after purchasing an additional 993,810 shares in the last quarter. Massachusetts Financial Services Co. MA bought a new stake in shares of Integer in the third quarter worth about $41,938,000. Bamco Inc. NY lifted its position in shares of Integer by 81.4% in the third quarter. Bamco Inc. NY now owns 766,055 shares of the medical equipment provider’s stock worth $79,156,000 after buying an additional 343,797 shares in the last quarter. Finally, William Blair Investment Management LLC bought a new position in Integer during the third quarter valued at approximately $28,459,000. 99.29% of the stock is currently owned by institutional investors.

Integer Price Performance

NYSE ITGR opened at $72.71 on Friday. The stock has a market capitalization of $2.55 billion, a price-to-earnings ratio of 30.42, a PEG ratio of 0.67 and a beta of 0.82. Integer has a 1-year low of $62.00 and a 1-year high of $146.36. The company has a debt-to-equity ratio of 0.70, a current ratio of 3.71 and a quick ratio of 2.45. The business’s fifty day moving average price is $78.66 and its 200-day moving average price is $99.98.

Integer (NYSE:ITGR) last issued its quarterly earnings data on Thursday, October 23rd. The medical equipment provider reported $1.79 EPS for the quarter, topping the consensus estimate of $1.68 by $0.11. Integer had a return on equity of 12.84% and a net margin of 4.75%.During the same period last year, the company earned $1.43 earnings per share. The firm’s quarterly revenue was up 8.4% on a year-over-year basis. Integer has set its FY 2025 guidance at 6.290-6.430 EPS. On average, equities analysts predict that Integer will post 6.01 earnings per share for the current year.

Integer declared that its Board of Directors has approved a share buyback program on Tuesday, November 4th that authorizes the company to repurchase $200.00 million in outstanding shares. This repurchase authorization authorizes the medical equipment provider to repurchase up to 8.3% of its shares through open market purchases. Shares repurchase programs are generally an indication that the company’s board believes its shares are undervalued.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.